Antiphospholipid (aPL)-Positive

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Antiphospholipid (aPL)-Positive trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT06722586

Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

The goal of this clinical trial is to learn the efficacy and safety of sirolimus in the treatment of anti-phospholipid antibody associated thrombocytopenia. The…

China84 participantsStarted 2025-01-07

Treatment: Sirolimus, Placebo

All recent trials (4 shown)

TerminatedPhase 3

NCT01784523

Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients

In this multi-center international study, our aim is to determine the effectiveness of HCQ for primary thrombosis prophylaxis in persistently aPL-positive but t…

United States11 participantsStarted 2013-02

Treatment: Hydroxychloroquine

TerminatedPhase 2

NCT02128269

Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome

The primary purpose of this study was to evaluate the safety and tolerability of intravenous (IV) ALXN1007 in persistently antiphospholipid (aPL)-positive patie…

United States, Brazil, France9 participantsStarted 2014-04

Treatment: Study Drug- ALXN1007

Antiphospholipid (aPL)-Positive

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

All recent trials (4 shown)

Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients

Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

All recent trials (4 shown)

Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients

Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome

Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Eryt…